Phio Pharmaceuticals Corp. (PHIO)
NASDAQ·Healthcare·Biotechnology
$1.10
+3.77%
Mkt Cap $13.08M
Analyst Ratings
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.10
+3.77%
Mkt Cap $13.08M
Buy
1
Hold
0
Sell
0
Price Target (— analysts)
—
Range — – —